Relapsed Tumors clinical trials at UCSF
1 in progress, 1 open to new patients
A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10
open to eligible people ages 18 years and up
This is an open-label Phase 1a/b dose-escalation study to assess the safety, tolerability, and PK of OMP-131R10 as a single agent for advanced solid tumors and in subjects with metastatic colorectal cancer.
San Francisco, California and other locations